Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
476 participants
INTERVENTIONAL
2019-09-09
2020-10-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
One of the recent research era in current obstetrics is the optimal intravenous (IV) hydration of the pregnant women in labor.Current evidences available in our hands, suggest that maternal hydration appears to fasten labor progress and enhance the action of oxytocin, if the later is used for augmentation. However, the addition of glucose supplementation to this IV hydration to enhance uterine contraction, as a matter of safety and efficacy, is controversial
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study on the Effects of Dextrose Solutions on the Course of Labor
NCT00569439
Effects of Rate and/or Presence of Dextrose on the Labor Course of Nulliparas
NCT01904617
Lactated Ringer's and Dextrose 5% vs Only Lactated Ringer's in Labor
NCT07124130
Use of Normal Saline With or Without Dextrose During Induction of Labor in Nulliparous
NCT02655783
Role Of Dexamethasone In Induction Of Labor
NCT03603418
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
study group
women who will receive 250 mL/hour of dextrose 5% with normal saline in a 1:1 ratio.
Dextrose 5%/Nacl 0.3% Inj_#3
250 mL/hour of dextrose 5% intravenous drip
Saline
250 mL/hour of normal saline intravenous drip
control group
women who will receive 250 mL/hour of normal saline for the whole duration of induction
Saline
250 mL/hour of normal saline intravenous drip
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dextrose 5%/Nacl 0.3% Inj_#3
250 mL/hour of dextrose 5% intravenous drip
Saline
250 mL/hour of normal saline intravenous drip
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Late Term Pregnancy ( gestational Age Between 40-42 weeks)
* Uncomplicated singleton pregnancy with cephalic presentation.
* Favorable cervix for induction (Bishop score\<6) without ruptured membranes.
Exclusion Criteria
* Non-cephalic presentations, multiple pregnancies, or cervix unfavorable for induction.
* Other indications for cesarean delivery
18 Years
45 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Suez Canal University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Salwa Hussein Ismaeil Tammam
principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Zakia M Ibraheim, MD
Role: STUDY_CHAIR
Professor of Gynecology and Obstetrics
Mariam L Mohammed, MD
Role: STUDY_DIRECTOR
Assistant Professor of Gynecology and Obstetrics
Hanan M Ghoneim, MD
Role: STUDY_DIRECTOR
Assistant Professor of Gynecology and Obstetrics
Ahmed M Abbas, MD
Role: STUDY_DIRECTOR
Assistant Professor of Gynecology and Obstetrics
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Suez canal University
Ismailia, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Salwa Hussein, MMBCh
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
4018
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.